Abstract: In order to develop and optimize metering strategies for fed-batch fermentations in two or more reaction vessels, release systems containing nutrients are attached to the inner surfaces of the reaction vessels in areas that will come into contact with culture liquid placed in the vessels.
Type:
Application
Filed:
April 26, 2006
Publication date:
April 23, 2009
Applicant:
RWTH AACHEN
Inventors:
Jochen Buchs, Doris Klee, Barbara Dittrich, Markus Jeude
Abstract: S-Adenosyl-L-methionine analogs of formula (I) wherein R comprises a carbon-carbon double bond, carbon-oxygen double bond, carbon-sulfur double bond, carbon-nitrogen double bond, a carbon-carbon triple bond, carbon-nitrogen triple bond or an aromatic carbocyclic or heterocyclic system in ?-position to the sulfonium center, X— is an organic or inorganic anion carrying one or more negative charges, Z is —CR1R2—, —O—, —S— or —NR3— and R1, R2 and R3 are independently selected from H, D and C1-C12 alkyl. Also disclosed are complexes of the compound with a methyltransferase, pharmaceutical compositions comprising the same, methods for modifying biomolecule using the compound, and methods for detecting sequences specific methylation of biomolecules using the compound.
Type:
Application
Filed:
October 11, 2007
Publication date:
January 15, 2009
Applicants:
RWTH AACHEN, INSTITUTE OF BIOTECHNOLOGY
Inventors:
Elmar Weinhold, Christian Dalhoff, Saulius Klimasauskas, Grazvydas Lukinavicius
Abstract: The invention relates to polypeptides of amino acid sequence SEQ ID NO: 1 according to formula (1), the use thereof for producing a medicament, and medicaments for the treatment of diseases related to monocyte recruitment.
Type:
Application
Filed:
October 11, 2006
Publication date:
November 20, 2008
Applicant:
RWTH AACHEN
Inventors:
Christian Weber, Philipp Von Hundelshausen, Rory Koenen
Abstract: Disclosed are reactive cyclic carbonates and ureas of formula (I) or (II), wherein R and X have the meaning indicated in the description. Said carbonates and ureas allow functional groups to be specifically introduced into biomolecules, polymers, and surfaces in mild conditions.
Type:
Application
Filed:
December 9, 2004
Publication date:
April 26, 2007
Applicant:
Deutsches Wollforschungsinstitut an der RWTH Aachen e.V.
Inventors:
Helmut Keul, Martin Moller, Nicolas Pasquier, Luc Ubaghs
Abstract: In order to improve a surgical holding device for holding a surgical instrument, with a frame, with a first linkage comprising at least two links, which articulatedly connects the frame to a first articulation point associated with the instrument, and with a second linkage comprising at least two links, which articulatedly connects the frame to a second articulation point associated with the instrument, so that a large range of action of the surgical instrument held by the holding device is adjustable as simply as possible, it is proposed that the links of the first linkage be mounted for pivotal movement about pivot axes relative to one another and relative to the frame, and that the pivot axes extend parallel to one another.
Type:
Application
Filed:
February 13, 2006
Publication date:
October 12, 2006
Applicants:
AESCULAP AG & Co. KG, RWTH Aachen
Inventors:
Manfred Fischer, Theodor Lutze, Klaus Radermacher, Markus Hahndorff, Wolfgang Lauer
Abstract: The invention provides an analogue of a pharmaceutical active whose molecular weight is less than 25,000 Daltons, the analogue comprising a pharmaceutical active whose molecular weight is less than 25,000 Daltons covalently linked to a pendant molecular group wherein as a result of the administration of the composition to the human or animal body an active complex having a molecular weight of 25,000 Daltons or greater is present in the human or animal circulatory system. The analogue is hepatoselective when administered to the circulatory system. Preferably the analogue is an insulin analogue comprising an insulin or functional equivalent thereof covalently linked to the pendant molecular group wherein the active complex is an insulin complex. Such an insulin analogue may be used in a method of insulin replacement therapy.
Type:
Grant
Filed:
June 15, 1998
Date of Patent:
May 16, 2000
Assignees:
Kings College London, Deutsches Wollforschuncsinstitut an der Rwth Aachen
Inventors:
Richard Henry Jones, Fariba Shojaee-Moradi, Peter Henri Sonksen, Dietrich Brandenburg, Achim Schuttler, Heike Eckey
Abstract: A porous, flow-through molded body, designed specifically for use in the removal of diesel soot particles from the exhaust gas of diesel engines. It includes a reciprocally closed honeycombed body made of silicon carbide and possessing the following features.wall thickness: 1.25.+-.0.5 mm;porosity: 55 to 60%;average pore diameter: 25 to 70 .mu.m;specific permeability: 20 to 100 nPm.In the production method, a starting powder of silicon or a mixture of silicon with portions of silicon carbide and/or carbon is combined with an organic binding agent that can be coked and molded into a green body. This is then subjected to a coking fire in an inert-gas atmosphere; the molded body obtained in this manner is then heated in the presence of nitrogen or a nitrogenous inert gas to a temperature where free silicon is converted with the carbon, in a reaction firing, to silicon carbide. Additionally, a recrystallization firing at greater than 2000.degree. C. is implemented.
Type:
Grant
Filed:
August 12, 1998
Date of Patent:
January 25, 2000
Assignees:
Verein zur Forederung des Instituts fur Prozess-und Anwendungstechnik Keramik an der RWTH Aachen e.V., Thomas Josef Heimbach GmbH & Co.
Inventors:
Horst R. Maier, Uwe Schumacher, Walter Best, Wolfgang Schafer